Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Recall Promus Heart Stent"

16:41 EDT 25th July 2014 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Transplantation

Heart Failure HF

Matching News

Boston Scientific launches Promus Premier everolimus-eluting platinum chromium coronary stent in Japan

US-based Boston Scientific has launched the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation durable polymer drug-eluting stent (DES), in Japan.

Boston Scientific gets Japanese OK for Promus Premier stent

Japanese regulators have given Boston Scientific the go-ahead to market its Promus Premier system, a coronary drug-eluting st -More- 

Boston Scientific reports strong performance data for Synergy stent system

Boston Scientific has reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the Synergy everolimus-eluting bioabsorbable polymer platinum c...

Boston Scientific Launches Everolimus-Eluting Coronary Stent In Japan

Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation has launched the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan....

Strong Performance Data Reported for SYNERGY Stent System Trial

EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile Boston Scientific Corporation reported positive three-year follow-up data for the EVOLVE clinical trial, com...

Terumo to invest in R&D of French firm's bioresorbable heart stent

Arterial Remodeling Technologies, a French maker of a bioresorbable drug-eluting heart stent, has entered into a research and -More- 

Novel coronary stent materials reduce heart inflammation risk

Tiny metal tubes called stents - which keep blood flowing through diseased coronary arteries by slowly releasing medication - have helped to save the lives of millions at risk of heart disease. Once i...

Manufacturer And Hospital Indicted To Compensate For Heart Stent Fracture

A Mentougou court required both the manufacturer and the hospital to compensate a patient due to a fracture of a cardiac stent implanted in the patient’s heart.

Matching PubMed Articles

Snare removal of a deformed coronary stent via radial artery during percutaneous intervention for acute myocardial infarction.

A 49-year-old man underwent emergent coronary angiography for acute inferior myocardial infarction (MI). After balloon angioplasty of culprit right coronary artery (RCA) occlusion, a Promus Element st...

Transapical mitral valve implantation: the Lutter valve.

  The development of transcatheter techniques for treatment of severe mitral valve regurgitation in the beating heart is focus of recent research. An off-pump treatment technique poses great benefits...

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES...

Secondary stent-in-stent self-expanding metallic stent placement for early stent occlusion due to mucosal oedema in the gastrojejunal anastomosis after palliative subtotal gastrectomy for locally advanced gastric cancer.

Herein, we report a case of early in-stent occlusion due to the ingrowth of soft oedematous mucosal tissue through the lattices of an uncovered stent, which was used for palliation of a postoperative...

Effect of Valve Design on the Stent Internal Diameter of a Bioprosthetic Valve: A Concept of True Internal Diameter and Its Implications for the Valve-in-Valve Procedure.

The goal of this study was to provide a measurement of the true internal diameter (ID) of various surgical heart valves (SHV) to facilitate the valve-in-valve (VIV) procedure. During a VIV procedure,...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement